Oxford, United Kingdom

Ronald K Yamamoto

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 339(Granted Patents)


Location History:

  • Redwood City, CA (US) (1990)
  • Atherton, CA (US) (1991)
  • Oxford, GB (2023)

Company Filing History:


Years Active: 1990-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ronald K Yamamoto

Introduction

Ronald K Yamamoto is a notable inventor based in Oxford, GB, recognized for his significant contributions to the field of ophthalmic drug compositions. With a total of four patents to his name, he has made strides in developing innovative drug formulations aimed at treating ocular diseases.

Latest Patents

Yamamoto's latest patents include groundbreaking work on ophthalmic drug compositions. One of his inventions provides a drug composition that comprises particles made from a biodegradable or bioerodable polymer, along with a drug, a soluble biodegradable excipient, a bulking agent, and a reconstitution aid. This invention also encompasses a pharmaceutical formulation and a unit dosage form of the formulation, offering methods for treating various diseases or conditions. Additionally, he has developed sterile lyophilized drug compositions and methods specifically designed for treating ocular diseases or conditions, further enhancing the therapeutic options available in this field.

Career Highlights

Throughout his career, Ronald K Yamamoto has worked with several prominent companies, including Vitaphore Corporation and Oxular Limited. His experience in these organizations has allowed him to refine his expertise in drug formulation and delivery systems, contributing to his success as an inventor.

Collaborations

Yamamoto has collaborated with notable professionals in his field, including Stanley R Conston and Robert Steven Bley. These partnerships have likely enriched his work and expanded the impact of his inventions.

Conclusion

In summary, Ronald K Yamamoto's innovative work in ophthalmic drug compositions has made a significant impact on the treatment of ocular diseases. His patents reflect a commitment to advancing medical science and improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…